Research analysts at StockNews.com assumed coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Get Free Report) in a research report issued on Wednesday. The brokerage set a “hold” rating on the biotechnology company’s stock.
Bellerophon Therapeutics Price Performance
Shares of NASDAQ:BLPH opened at $0.06 on Wednesday. The stock’s 50-day moving average is $0.06 and its 200 day moving average is $0.05. The company has a market cap of $684,880.00, a PE ratio of -0.07 and a beta of 0.73. Bellerophon Therapeutics has a 1 year low of $0.03 and a 1 year high of $0.76.
Bellerophon Therapeutics Company Profile
Featured Articles
- Five stocks we like better than Bellerophon Therapeutics
- Consumer Discretionary Stocks Explained
- RXO Shares Surge Following New Acquisition Deal
- How to Effectively Use the MarketBeat Ratings Screener
- 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
- 3 REITs to Buy and Hold for the Long Term
- Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Receive News & Ratings for Bellerophon Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bellerophon Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.